neurexin I Activators
Neurexin I activators encompass a diverse array of chemicals that directly or indirectly enhance the function of neurexin I, a crucial player in synaptic processes. Forskolin, a potent adenylate cyclase activator, directly activates neurexin I by increasing intracellular cAMP levels, amplifying its involvement in cAMP-dependent pathways that govern synaptic function. Another direct activator, 1-oleoyl-2-acetyl-sn-glycerol, stimulates protein kinase C (PKC), phosphorylating and activating neurexin I, thereby influencing its role in synaptic processes and neurotransmitter release.
Additionally, compounds like Sp-cAMPS, Bay K 8644, PMA, IBMX, Phorbol 12,13-dibutyrate, FPL 64176, Cholera Toxin, NS309, 8-Bromo-cGMP, and SKF 96365 directly or indirectly activate neurexin I through diverse mechanisms. These include calcium channel activation, cyclic nucleotide analogs, and small-conductance calcium-activated potassium (SK) channel modulation. These activators directly influence neurexin I at the molecular level, enhancing its participation in synaptic processes and neurotransmitter release. Understanding the specific biochemical pathways impacted by these chemicals provides valuable insights into the modulation of neurexin I function. Forskolin, for instance, directly targets cAMP-dependent pathways, while Bay K 8644 and SKF 96365 influence neurexin I through calcium channel activation. These activators offer precise tools for researchers to manipulate neurexin I activity, unraveling the intricate molecular mechanisms governing synaptic communication.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an adenylate cyclase activator, directly activates neurexin I by increasing intracellular cAMP levels. Neurexin I function is modulated by cAMP-dependent pathways, and Forskolin's activation of adenylate cyclase enhances cAMP production. Elevated cAMP levels result in the activation of neurexin I, influencing its role in synaptic processes. | ||||||
1-Oleoyl-2-acetyl-sn-glycerol (OAG) | 86390-77-4 | sc-200417 sc-200417A | 10 mg 50 mg | $119.00 $453.00 | 1 | |
1-oleoyl-2-acetyl-sn-glycerol, a diacylglycerol analog, directly activates neurexin I through protein kinase C (PKC) activation. Neurexin I is linked to PKC signaling, and this diacylglycerol analog stimulates PKC, leading to the phosphorylation and activation of neurexin I. | ||||||
Sp-cAMPS | 93602-66-5 | sc-201571 | 1 mg | $97.00 | 3 | |
Sp-cAMPS, a cyclic AMP analog, directly activates neurexin I by mimicking the intracellular signaling molecule cAMP. Neurexin I function is intricately tied to cAMP-dependent pathways, and Sp-cAMP serves as a direct activator by stimulating downstream effectors of cAMP signaling. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K 8644, a calcium channel activator, directly influences neurexin I by promoting calcium influx. Neurexin I function involves calcium-dependent processes at the synapse, and Bay K 8644 facilitates calcium entry into cells, directly impacting neurexin I-mediated synaptic activities by promoting the availability of calcium ions required for proper neurotransmitter release. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, a PKC activator, directly activates neurexin I through the stimulation of protein kinase C. Neurexin I is connected to PKC signaling, and PMA induces the activation of PKC, leading to the phosphorylation and activation of neurexin I. The direct activation by PMA enhances neurexin I-mediated synaptic processes, influencing neurotransmitter release and synaptic communication. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, a phosphodiesterase inhibitor, directly activates neurexin I by increasing intracellular cAMP levels. Neurexin I function is modulated by cAMP-dependent pathways, and IBMX inhibits phosphodiesterase, preventing cAMP degradation. Elevated cAMP levels result in the direct activation of neurexin I, influencing its role in synaptic processes and neurotransmitter release. | ||||||
Phorbol-12,13-dibutyrate | 37558-16-0 | sc-202285 | 1 mg | $124.00 | 3 | |
Phorbol 12,13-dibutyrate, a PKC activator, directly influences neurexin I through the stimulation of protein kinase C. Neurexin I is linked to PKC signaling, and Phorbol 12,13-dibutyrate induces the activation of PKC, leading to the phosphorylation and activation of neurexin I. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
FPL 64176, a calcium channel activator, directly influences neurexin I by promoting calcium influx. Neurexin I function involves calcium-dependent processes at the synapse, and FPL 64176 facilitates calcium entry into cells, directly impacting neurexin I-mediated synaptic activities by promoting the availability of calcium ions required for proper neurotransmitter release. | ||||||
NS309 | 18711-16-5 | sc-253202 | 5 mg | $110.00 | ||
NS309, a small-conductance calcium-activated potassium (SK) channel activator, directly influences neurexin I through SK channel activation. Neurexin I function is linked to SK channel signaling, and NS309 activates SK channels, leading to changes in intracellular calcium levels. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cGMP, a cyclic GMP analog, directly activates neurexin I by mimicking the intracellular signaling molecule cGMP. Neurexin I function is intricately tied to cGMP-dependent pathways, and 8-Bromo-cGMP serves as a direct activator by stimulating downstream effectors of cGMP signaling. | ||||||